<DOC>
	<DOCNO>NCT01077609</DOCNO>
	<brief_summary>This inception cohort study analyse data administrative medical record database . The two inception cohort : 1 ) patient initiate intranasal FP 2 ) patient initiate another INS ( FP ) . The candidate inception cohort use intranasal steroid year prior initiation .</brief_summary>
	<brief_title>Flixonase Safety Patients With Allergic Rhinitis ( AR )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Patient record date January 1990 January 2002 use develop overall study cohort . The cohort compose follow patient : 1 . All patient least one prescription Flixonase 2 . A random sample patient least one prescription INS Flixonase Patientlevel exclusion Patients le 180 day continuous eligibility index date Patients four year age index date Patients older 85 year age index date Episodelevel exclusion When patient history divide Flixonase INS use episode , patient le 120 day eligibility last prescription episode Patients event interest 180 day prior patient ' entry cohort anytime prior episode index date automatically exclude analysis event . This exclusion criterion apply rule prevalent condition .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Intranasal steroid</keyword>
	<keyword>beclometasone diproprionate</keyword>
	<keyword>steroid-related outcome</keyword>
</DOC>